Patents by Inventor Hiroatsu Matsumoto

Hiroatsu Matsumoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors
    Publication number: 20060116337
    Abstract: The object of the present invention is to provide the use of glycyrrhizin and its derivatives for inhibition of MCP-1 production. The present invention discloses an MCP-1 production inhibition method and pharmaceutical composition for the same comprising administration of glycyrrhizin and its derivatives in an amount effective for said inhibition to mammals in which migration of monocytes or T lymphocytes is increased, or production of IL-10 is increased, and inhibition of said increase is desired, thereby treating or preventing decreases in infection resistance.
    Type: Application
    Filed: November 1, 2005
    Publication date: June 1, 2006
    Inventors: Fujio Suzuki, Makiko Kobayashi, Tokuichiro Utsunomiya, Hiroatsu Matsumoto, Midori Takeda, Shigemi Iwata
  • Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors
    Patent number: 7015202
    Abstract: The object of the present invention is to provide the use of glycyrrhizin and its derivatives for inhibition of MCP-1 production. The present invention discloses an MCP-1 production inhibition method and pharmaceutical composition for the same comprising administration of glycyrrhizin and its derivatives in an amount effective for said inhibition to mammals in which migration of monocytes or T lymphocytes is increased, or production of IL-10 is increased, and inhibition of said increase is desired.
    Type: Grant
    Filed: October 23, 2003
    Date of Patent: March 21, 2006
    Assignee: Minophagen Pharmaceutical Co., Ltd.
    Inventors: Fujio Suzuki, Makiko Kobayashi, Tokuichiro Utsunomiya, Hiroatsu Matsumoto, Midori Takeda, Shigemi Iwata
  • Use of glycyrrhizin and its derivatives as RANTES inducers
    Publication number: 20040142882
    Abstract: The object of the present invention is to provide the use of glycyrrhizin and its derivatives for induction of RANTES. The present invention discloses an RANTES induction method and pharmaceutical composition for the same comprising administration of glycyrrhizin and its derivatives in an amount effective for treating or preventing decreases in infection resistance to opportunistic infections occurring in burn patients, AIDS patients, cancer patients, encephalitis patients, individuals having suffered serious injuries or undergone major surgery, or individuals subject to stress.
    Type: Application
    Filed: October 27, 2003
    Publication date: July 22, 2004
    Inventors: Fujio Suzuki, Makiko Kobayashi, Tokuichiro Utsunomiya, Hiroatsu Matsumoto, Midori Takeda, Shigemi Iwata
  • Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors
    Publication number: 20040138171
    Abstract: The object of the present invention is to provide the use of glycyrrhizin and its derivatives for inhibition of MCP-1 production. The present invention discloses an MCP-1 production inhibition method and pharmaceutical composition for the same comprising administration of glycyrrhizin and its derivatives in an amount effective for said inhibition to mammals in which migration of monocytes or T lymphocytes is increased, or production of IL-10 is increased, and inhibition of said increase is desired.
    Type: Application
    Filed: October 23, 2003
    Publication date: July 15, 2004
    Inventors: Fujio Suzuki, Makiko Kobayashi, Tokuichiro Utsunomiya, Hiroatsu Matsumoto, Midori Takeda, Shigemi Iwata